5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine(91147-46-5)
- Name: 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- Synonyms:
- Molecular Formula:C11H10ClN5
- Molecular Weight:247.687
- CAS Registry Number:91147-46-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.91147-46-5 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.91147-46-5 Brimonidine EP Impurity H
Assay:99.90% Appearance:Solid Storage:Protect from light and keep dry Application:Pharmaceutical intermediates
Min. Order:0
Supplier:ORCHID CHEMICAL SUPPLIES LTD [
China (Mainland)] CAS No.91147-46-5 Brimonidine Impurity H
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.91147-46-5 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.91147-46-5 Brimonidine Impurity H
Assay:> 95% Package:inquiry Transportation:inquiry Application:Brimonidine Impurity H is structurally related to Brimonidine.
Min. Order:1Gram
Supplier:BOC Sciences [
United States]
Other Product
- 21829-26-5/diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
- 90749-56-7/1H-Purine-2,6-dione, 3,7-dihydro-1,7-dimethyl-8-(3-(4-(diphenylmethoxy)-1-piperidinyl)propyl)-3-(2-methylpropyl)-, (E)-2-butenedioate (1:1)
- 80449-04-3/BGL I
- 10219-69-9/13(R)-HODE
- 84-42-4/N-(3-chloro-9,10-dihydro-9,10-dioxo-2-anthryl)acetamide
- 74246-82-5/Spiro(naphthalene-1(2H),3-pyrrolidine)-2,5-dione, 3,4-dihydro-1-(3-(1-pyrrolidinyl)propyl)-, hydrochloride, (+-)-
- 2425-01-6/1,4-BIS(GLYCIDYLOXY)BENZENE
- 121055-54-7/N(2),3-etheneodeoxyguanosine-5'-triphosphate
- 1000-87-9/TETRAMETHYLALLENE
- 105919-41-3/2,6-dimethyl-1-{(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoyl}piperidine
- 7460-58-4/2,3-bis(benzoyloxy)-4-methoxy-4-oxobutanoic acid
- 111786-59-5/1,3-Benzodioxole-5-butanol,a-1,3-benzodioxol-5-yl-b,g-dimethyl-, (aR,bS,gR)-
- 17627-41-7/hexyl 3-methyl-2-butenoate
- 68155-15-7/Amides, from 2-((2-aminoethyl)amino)ethanol and hydrogenated tallow, acetates (salts)
- 5397-06-8/N~2~,N~2~-bis(2-methylprop-2-en-1-yl)-1,3,5-triazine-2,4,6-triamine
- 20069-03-8/Nitrarine
- 7155-00-2/NSC57674
- 115621-49-3/1,5-dihydro-4-(4-(1H-imidazol-1-yl)phenyl)-3-methyl-2H-pyrrol-2-one
- 1681-10-3/6-methyl-1H-purin-2-amine
- 91147-46-5/5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- 1163-54-8/4-FLUORO-N-METHOXY-N-METHYLBENZAMIDE
- 5931-14-6/3-methyl-1-{4-[4-(methylsulfanyl)benzyl]piperazin-1-yl}butan-1-one
- 5341-07-1/3-BROMO-8-NITROQUINOLINE
- 14047-45-1/ethyl N-{(2Z)-3-[bis(2-chloroethyl)amino]prop-2-enoyl}glycinate
- 20145-50-0/1-(methoxymethyl)-2,3,4,5,6-pentamethylbenzene
- 60678-74-2/1,1-dimethyl-2,2-bis(2-methylpropyl)hydrazine
- 6267-91-0/2-methyl-8-thioxo-3,7,8,9-tetrahydro-6H-purin-6-one
- 149792-62-1/1-Oxa-7-azaspiro[4.4]non-2-ene-4,6-dione,8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-,(5S,8R,9R)-
- 6700-69-2/Allobergapten
- 10290-03-6/Dibenzo[def,mno]chrysene-6,12-diol,4,10-dibromo-, 6,12-bis(hydrogen sulfate), sodium salt (1:2)